miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer

S Zhong, H Golpon, P Zardo, J Borlak - Translational Research, 2021 - Elsevier
Lung cancer (LC) is the leading cause of cancer-related death worldwide and miRNAs play
a key role in LC development. To better diagnose LC and to predict drug treatment …

[HTML][HTML] Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment

A Mafi, A Rahmati, Z Babaei Aghdam, R Salami… - Cellular & Molecular …, 2022 - Springer
Gliomas are the most lethal primary brain tumors in adults. These highly invasive tumors
have poor 5-year survival for patients. Gliomas are principally characterized by rapid …

[HTML][HTML] YKT6 expression, exosome release, and survival in non-small cell lung cancer

M Ruiz-Martinez, A Navarro, RM Marrades, N Viñolas… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Background Cancer-derived exosomes are involved in metastasis. YKT6 is a SNARE
protein that participates in the regulation of exosome production and release, but its role in …

[HTML][HTML] miR-134: a human cancer suppressor?

JY Pan, F Zhang, CC Sun, SJ Li, G Li, FY Gong… - … Therapy-Nucleic Acids, 2017 - cell.com
MicroRNAs (miRNAs) are small noncoding RNAs approximately 20–25 nt in length, which
play crucial roles through directly binding to corresponding 3′ UTR of targeted mRNAs. It …

MicroRNA-187-3p mitigates non-small cell lung cancer (NSCLC) development through down-regulation of BCL6

C Sun, S Li, C Yang, Y Xi, L Wang, F Zhang… - … and biophysical research …, 2016 - Elsevier
Abstract Hsa-microRNA-187-3p (miR-187-3p) has recently been discovered having
anticancer efficacy in different organs. However, the role of miR-187-3p on non-small cell …

The role of MicroRNAs in lung cancer: implications for diagnosis and therapy

P Naeli, F Yousefi, Y Ghasemi… - Current molecular …, 2020 - ingentaconnect.com
Lung cancer is the first cause of cancer death in the world due to its high prevalence,
aggressiveness, late diagnosis, lack of effective treatment and poor prognosis. It also shows …

miR‐134 targets PDCD7 to reduce E‐cadherin expression and enhance oral cancer progression

SY Peng, HF Tu, CC Yang, CH Wu… - … journal of cancer, 2018 - Wiley Online Library
Oral squamous cell carcinoma (OSCC) is a common malignancy worldwide. This study
clarified the oncogenic role of miR‐134 in OSCC. Reporter assays, using both wild‐type and …

[HTML][HTML] Cell behavior of non-small cell lung cancer is at EGFR and microRNAs hands

SS Hassanein, SA Ibrahim… - International journal of …, 2021 - mdpi.com
Lung cancer is a complex disease associated with gene mutations, particularly mutations of
Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) and epidermal growth factor receptor …

MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1

M Mao, Z Wu, J Chen - Biochemical and biophysical research …, 2016 - Elsevier
Lung cancer remains a leading cause of cancer-associated mortality worldwide and non-
small lung cancer (NSCLC) is responsible for over 80% of lung cancer-related deaths …

[PDF][PDF] miR-3175 and miR-134 affect proliferation, invasion and apoptosis of glioma cells through PI3K/AKT signaling pathway

A Qi, J Han, F Jia, C Liu - J buon, 2019 - jbuon.com
Purpose: This study aimed to investigate the expressions of microRNA (miR)-3175 and miR-
134 in gliomas and their effects on the proliferation and invasion of U251 glioma cells …